Probiotics, Brain Structure and Psychological Variables (ProBrain01)
Depressive Symptoms, Anxiety, Stress

About this trial
This is an interventional basic science trial for Depressive Symptoms focused on measuring Probiotics, Psychiatric Symptoms, Cognitive Function, Hippocampus, Oxytocin, Immunological Parameters
Eligibility Criteria
Inclusion Criteria:
- healthy participants
- age 18-40
- informed consent for all parts of the study (including MRT)
- none of the exclusion criteria (see below) fulfilled
Exclusion Criteria:
- age < 18 or > 40 years
- pregnancy or breastfeeding
- left-handedness
- degenerative or inflammatory diseases of the central nervous system
- severe cognitive/ neuropsychological impairment
- severe pain syndrome or other severe organic diseases
- epilepsy
- (past or present) psychiatric disorders
- neurological disorder
- severe diabetic polyneuropathy
- malignancies/ cancer
- cardiac insufficiency
- arterial hypertension
- heart attack/ stroke
- severe hepatic or renal insufficiency
- diseases of the hemopoietic system
- alcoholism/ drug addiction
- medical history of severe allergic or toxic reactions
- current participation in drug trial
- doubts about legal capacity/ capability of understanding
- referral to institutions based on court/ official order
- treatment with centrally acting medication (e.g. antipsychotics, antiepileptics, antidepressants, etc.)
- non-removable metal pieces (aneurysm clips, artificial limbs, etc.) or implanted electronic devices (pacemaker, osmotic or other implanted pumps, cochlear implants, etc.)
- claustrophobia
- acute (respiratory) infection, physical uneasiness
- tattoos in the head region, permanent make-up
- non-removable piercings
- chronic/ acute gastrointestinal diseases
- vegetarianism, veganism
- current intake of antibiotics or intake of antibiotics at any time point during the last 2 months
- lactose intolerance
- general focus on probiotic diet
Sites / Locations
- Universitätsklinikum Hamburg-Eppendorf, Klinik und Poliklinik für Psychiatrie und Psychotherapie
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
verum condition probiotics
placebo condition
The verum condition probiotics in the present study is a freely available product, Vivomixx® powder (dietary supplement). Each dose (4.4g) contains 450 billion bacteria, composed of eight bacterial strains: Lactobacilli (L. paracasei, L. plantarum, L. acidophilus, L.delbrueckii subsp. bulgaricus), Bifidobacteria (B. longum, B. infantis, B. breve), and Streptococcus thermophiles. 30 Participants will be randomly assigned to this condition. The intake period is 28 days, daily dose = 4.4g.
In the placebo condition participants will receive a placebo powder (comparable in taste and consistency to Vivomixx® = verum condition probiotics) that contains no probiotic bacteria. 30 Participants will be randomly assigned to that condition. The intake period is 28 days, daily dose = 4.4g.